ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.
Related Questions
What is the expected impact of the 15% YoY revenue growth on GRDN's stock price?
What portion of the revenue growth is attributable to organic growth versus recent acquisitions?
How might the modest net income of $8 (versus prior periods) affect investor sentiment and valuation multiples?
How does the updated guidance align with analyst consensus estimates for the full year?
What is the cash flow outlook for the remainder of 2025 given the recent growth and acquisition activity?
Could the increase in resident count lead to higher operating leverage or pressure on supply chain capacity?
How does the 12% increase in resident count compare to industry peers in the LTC pharmacy sector?
What are the potential risks or upside scenarios surrounding the integration of newly acquired facilities?
Are the raised full‑year guidance and Q2 results sustainable given the current market environment?
What are the margins and profitability trends relative to competitors after accounting for acquisition integration costs?